Tandem Diabetes Care (TNDM) Deferred Taxes (2013 - 2019)
Tandem Diabetes Care's (TNDM) quarterly Deferred Taxes came in at -$25000.0 in Q4 2019, up 62.85% on a QoQ basis from -$67286.0 in Q1 2014.
Tandem Diabetes Care (TNDM) Deferred Taxes (2013 - 2019) Analysis & Trends
Tandem Diabetes Care (TNDM) has 3 years of Deferred Taxes data on file, last reported at -$25000.0 in Q4 2019.
- Quarterly Deferred Taxes changed N/A year-over-year to -$25000.0 in Q4 2019, while the trailing twelve-month figure through Sep 2021 was -$25000.0 (up 72.91% YoY) and the FY2020 annual result came in at -$2.1 million, down 8404.0% from the prior year.
- Deferred Taxes advanced to -$25000.0 in Q4 2019, from -$67286.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of -$25000.0 in Q4 2019 to a low of -$25000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 107.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 17.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -181.30 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -300,000.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 235.96 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 600,000.00 |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -25,000.00 |
| Mar 31, 2014 | -67,286.00 |
| Mar 31, 2013 | -141,137.00 |